P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: a systematic review and meta-analysis
In the setting of HF, SGLT2is reduced the risk of HHF, irrespective of ejection fraction or diabetes status [6, 28, 76, 79]
The SURMOUNT-5 trial, published in The New England Journal of Medicine in May 2025, is the first large randomized study to compare tirzepatide and semaglutide directly in adults with obesity
For mothers navigating the complex intersection of GLP-1 therapy and breastfeeding, having access to comprehensive, up-to-date research, dosage calculators , and protocol guidance can make the difference between informed confidence and anxious guessing
[27] In pediatric cryptorchidism, dosing may range from 500 IU three times weekly for 3 weeks to 4,000 IU three times weekly for 6 weeks, based on clinical protocol